Autoimmune & autoinflammatory
Mastocytic enterocolitis
Mastocytic enterocolitis is a proposed explanation for some treatment-resistant chronic diarrhoea: excess mast cells in the gut lining found on special staining - a diagnosis that exists at the research frontier.
Key points
The essentials at a glance.
What to look out for, which tests matter, who treats it, and what usually happens next.
-
The concept: chronic diarrhoea or IBS-like symptoms with increased mast cells on colon or duodenal biopsies stained specifically for them
-
Routine biopsy processing does not count mast cells - the tryptase stain must be requested
-
No consensus threshold defines abnormal - mast cell counts overlap between patients and healthy controls, which is the core controversy
-
Distinct from systemic mastocytosis and from MCAS, though the concepts intersect
-
A trial of mast-cell-directed therapy (H1 and H2 antihistamines, cromoglicate) is low-risk and sometimes strikingly effective
Understanding it
About Mastocytic enterocolitis.
The observation is real: studies of patients with intractable diarrhoea-predominant IBS have found higher average mast cell densities in gut biopsies than in controls, and mast cell mediators visibly alter gut secretion, motility and nerve sensitivity. The dispute is whether a count constitutes a disease - healthy people vary widely, laboratories differ in staining and counting methods, and mainstream gastroenterology has not adopted diagnostic criteria, so the same biopsy can be normal in one institution and mastocytic enterocolitis in another. Honest clinics say so out loud.
A pragmatic route treats the finding as a signpost rather than a verdict: exclude the established diagnoses first - microscopic colitis (the important lookalike, also needing specific biopsy assessment), coeliac disease, bile acid diarrhoea, giardia - then, where mast cell density is high, run a structured trial of antihistamines and cromoglicate with a symptom diary and a defined review date. Improvement justifies continuing; no improvement means the search resumes rather than the label hardening. In many parts of the UK, a routine NHS referral to the relevant specialist clinic currently means waiting many months - sometimes more than a year for the rarest conditions - whereas an initial appointment with a private consultant is typically available within around two weeks, with investigations arranged soon after.
Frequently asked
Common questions about Mastocytic enterocolitis.
Quick, plain-English answers to what people ask us most.
-
What is mastocytic enterocolitis?
Mastocytic enterocolitis is a condition where increased numbers of mast cells are found in the lining of the bowel, associated with chronic diarrhoea and abdominal symptoms, though its exact clinical significance remains debated among specialists. It's sometimes identified during investigation of otherwise unexplained chronic diarrhoea.
-
What causes mastocytic enterocolitis?
The exact cause isn't fully understood, and it may represent one manifestation of broader mast cell activation issues, or a distinct localised finding within the bowel. Research into the underlying mechanisms and its relationship to other mast cell conditions continues to evolve.
-
What are the symptoms of mastocytic enterocolitis?
The main symptom is chronic, often watery diarrhoea, sometimes with abdominal pain or bloating, persisting despite standard investigation and treatment for more common causes of diarrhoea. Symptoms can significantly affect quality of life given their chronic nature.
-
Is mastocytic enterocolitis dangerous?
It's not typically dangerous in the sense of causing serious organ damage, but chronic diarrhoea can significantly affect quality of life and, if severe, contribute to nutritional or fluid balance problems. Appropriate treatment can usually improve symptoms and quality of life.
-
Is mastocytic enterocolitis hereditary?
There's no well-established hereditary pattern currently identified for this specific condition. It's an area still being researched to better understand any genetic or other predisposing factors.
-
Can mastocytic enterocolitis be treated?
Yes, treatment often includes mast cell stabilising medications and antihistamines, similar to approaches used for other mast cell-related conditions, alongside general management of diarrhoea symptoms. Response to treatment varies between individuals, and some trial and adjustment of approach may be needed.
-
How is mastocytic enterocolitis diagnosed?
Diagnosis typically involves colonoscopy with biopsies showing increased mast cell numbers on specialised staining, usually after other more common causes of chronic diarrhoea have been excluded through standard investigation. This is generally considered after a thorough standard gastroenterology work-up hasn't found another explanation.
-
How is mastocytic enterocolitis treated?
Treatment typically involves antihistamines and mast cell stabilising medications, sometimes alongside dietary modifications and general symptomatic treatment for diarrhoea. Your gastroenterologist will tailor the approach based on your specific symptom pattern and response to initial treatment.
-
Mastocytic enterocolitis vs irritable bowel syndrome — what's the difference?
Both can cause chronic diarrhoea and abdominal discomfort without an obvious structural cause, but mastocytic enterocolitis is specifically identified by increased mast cells found on bowel biopsy, whereas irritable bowel syndrome is diagnosed based on symptom patterns without such specific biopsy findings. Colonoscopy with biopsy is needed to identify the mastocytic pattern specifically.
-
When should I see a specialist about mastocytic enterocolitis, and how quickly can I be seen privately?
Persistent, unexplained chronic diarrhoea not responding to standard initial treatment should be assessed by a gastroenterologist. Private gastroenterology consultations can typically be arranged within about two weeks, considerably faster than standard NHS waiting times.